Pfizer Valuation Sheet

Comparable Valuation Sheet PFE JNJ MRK LLY P/E Forward (fye Dec 31, 2014) 13.59x 16.87x 13.71x 18.2x PEG 12 month forward 3.94x 2.65x 5.49x 101.87x Revenues 2012 $58.90bn $69.99bn $46.21bn $22.6bn Market Cap $206.34bn $259.06bn $144.31bn $57.48bn Gross Margin 2012 81% 67.8% 65% 78.7% EBITDA 2012 $25.34bn $22.39bn $16.36bn $6.47bn Debt to Equity 48.78% 23.77% 37.45% 37.44% SOURCES: BIDNESS Company Data, SEC filings, Bloomberg Professional Services ec. DISCLAIMER Bidness Etc(TM) and related marks are owned by Bidness Etc. Any other trademarks appearing on this website are the property of their respective owners, and are not used to indicate the origin of goods or services offered or provided by Bidness Etc herein or to suggest approval for or affiliation with Bidness Etc. Pfizer Stock Price Based on Different Multiples SEP Pharmaceutical P/E 20.51x Forecasted EPS (Dec 2014) $2.18 Pfizer Stock Price $44.7 SEP 500 Multiple 15x Forecasted EPS (Dec 2014) $2.18 Pfizer Stock Price $32.7 Eli Lilly P/E 18.17 Forecasted EPS (Dec 2014) $2.18 Pfizer Stock Price $39.6 Pfizer 5yr historic average forward P/E 9.08x Forecasted EPS (Dec 2014) $2.18 Pfizer Stock Price $19.8 SOURCES: Company Data, SEC filings, Bloomberg Professional Services BIDNESS DISCLAIMER: Bidness Etc(TM) and related marks are owned by Bidness Etc. Any other trademarks appearing on this website are the property of their respective owners, and are not used to indicate the origin of goods or services offered or provided by Bidness Etc herein or to suggest approval for or affiliation with Bidness Etc.